Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -66.03% is 110% below its 3-year average of -31.41%, near the low end of its 3-year range (-66.03%–-12.20%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.95% below its 12-month average of -49.67%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -66.03%.
RETURN ON INVESTED CAPITAL (ROIC)
-66.03%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-49.67%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-33.01%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-32.95%
CURRENT VS 3Y AVG
-100.05%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
-85.16%
vs the sector median at left
Metagenomi, Inc. Common Stock
Market Cap
$38.78M
Return on Invested Capital (ROIC)
-66.03%
TTM Avg
-49.67%
3Y Avg
-33.01%
5Y Avg
N/A
Market Cap
$38.61M
Return on Invested Capital (ROIC)
1.99%
TTM Avg
-3.38%
3Y Avg
-2.67%
5Y Avg
-1.50%
Market Cap
$37.93M
Return on Invested Capital (ROIC)
-32.18%
TTM Avg
-103.25%
3Y Avg
-133.41%
5Y Avg
-116.42%
Market Cap
$39.64M
Return on Invested Capital (ROIC)
-60.64%
TTM Avg
-93.35%
3Y Avg
-138.83%
5Y Avg
-96.86%
Market Cap
$36.21M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-107.47%
3Y Avg
-107.47%
5Y Avg
-107.47%
Market Cap
$35.84M
Return on Invested Capital (ROIC)
-171.36%
TTM Avg
-234.34%
3Y Avg
-204.54%
5Y Avg
-189.00%
Market Cap
$35.84M
Return on Invested Capital (ROIC)
-166.02%
TTM Avg
-208.81%
3Y Avg
-185.70%
5Y Avg
-165.34%
Market Cap
$35.76M
Return on Invested Capital (ROIC)
-89.44%
TTM Avg
-27.62%
3Y Avg
-11.28%
5Y Avg
-9.71%
Market Cap
$41.83M
Return on Invested Capital (ROIC)
-8.43%
TTM Avg
-19.61%
3Y Avg
-40.73%
5Y Avg
-42.38%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Metagenomi, Inc. Common Stock (MGX) | $38.78M | -66.03% | -49.67% | -33.01% | N/A |
| Harvard Bioscience, Inc. (HBIO)vs › | $38.61M | 1.99% | -3.38% | -2.67% | -1.50% |
| Incannex Healthcare Limited (IXHL)vs › | $37.93M | -32.18% | -103.25% | -133.41% | -116.42% |
| Veru Inc. (VERU)vs › | $39.64M | -60.64% | -93.35% | -138.83% | -96.86% |
| EUDA Health Holdings Limited (EUDA)vs › | $36.21M | N/A | -107.47% | -107.47% | -107.47% |
| Elicio Therapeutics, Inc. (ELTX)vs › | $35.84M | -171.36% | -234.34% | -204.54% | -189.00% |
| Edesa Biotech, Inc. (EDSA)vs › | $35.84M | -166.02% | -208.81% | -185.70% | -165.34% |
| DocGo Inc. (DCGO)vs › | $35.76M | -89.44% | -27.62% | -11.28% | -9.71% |
| Precipio, Inc. (PRPO)vs › | $41.83M | -8.43% | -19.61% | -40.73% | -42.38% |
| BioStem Technologies, Inc. (BSEM)vs › | $41.95M | -80.92% | 33.73% | -139.74% | -139.74% |
ROIC
-66.0%
ROE
-83.0%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -66.03% |
| 2026-03-31 | -53.18% |
| 2025-12-31 | -48.45% |
| 2025-09-30 | -42.26% |
| 2025-06-30 | -38.41% |
| 2025-03-31 | -33.99% |
| 2024-12-31 | -30.94% |
| 2024-09-30 | -28.30% |
| 2024-06-30 | -26.56% |
| 2024-03-31 | -25.99% |
| 2023-12-31 | -26.52% |
| 2023-09-30 | -23.32% |
| 2023-06-30 | -18.16% |
| 2022-12-31 | -12.20% |
